These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26334204)

  • 1. Overcoming cancer resistance.
    Cook KL; Clarke R
    Future Med Chem; 2015 Aug; 7(12):1471. PubMed ID: 26334204
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeted therapy: overcoming drug resistance with clinical cancer genome.
    Ziogas DE; Katsios CS; Tzaphlidou M; Roukos DH
    Expert Rev Anticancer Ther; 2012 Jul; 12(7):861-4. PubMed ID: 22845399
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Multi-target Drug Discovery - Part II.
    Chen JN
    Curr Top Med Chem; 2017 Nov; 17(28):3081-3083. PubMed ID: 29197319
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer and natural selection.
    Fillon M
    J Natl Cancer Inst; 2012 Dec; 104(23):1773-4. PubMed ID: 23213180
    [No Abstract]   [Full Text] [Related]  

  • 5. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 6. Crossroad between linear and nonlinear transcription concepts in the discovery of next-generation sequencing systems-based anticancer therapies.
    Roukos DH
    Drug Discov Today; 2016 Apr; 21(4):663-73. PubMed ID: 26912452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network systems biology for targeted cancer therapies.
    Zhou TT
    Chin J Cancer; 2012 Mar; 31(3):134-41. PubMed ID: 22176777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy for malignant tumors: problems and prospects].
    Orlova RV; Vaizyan RI; Ivanova AK; Tikhonova EK; Zorina EY
    Vopr Onkol; 2015; 61(2):244-51. PubMed ID: 26087606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatic alterations as the basis for resistance to targeted therapies.
    Blair BG; Bardelli A; Park BH
    J Pathol; 2014 Jan; 232(2):244-54. PubMed ID: 24114654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preface: National Cancer Act.
    Smalley KS
    Adv Pharmacol; 2012; 65():xi-xiii. PubMed ID: 22959037
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting autophagy to overcome drug resistance in cancer therapy.
    Kumar A; Singh UK; Chaudhary A
    Future Med Chem; 2015 Aug; 7(12):1535-42. PubMed ID: 26334206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key drivers of biomedical innovation in cancer drug discovery.
    Huber MA; Kraut N
    EMBO Mol Med; 2015 Jan; 7(1):12-6. PubMed ID: 25422355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, clinical indications, and resistance mechanisms in molecular targeted therapies in cancer.
    Izar B; Rotow J; Gainor J; Clark J; Chabner B
    Pharmacol Rev; 2013; 65(4):1351-95. PubMed ID: 24092887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in the Discovery of Novel Therapeutic Agents in Cancer.
    Nagaraju GP; Kamal MA
    Curr Drug Metab; 2019; 20(12):931-932. PubMed ID: 31989914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1.
    Gillet JP; Gottesman MM
    Drug Resist Updat; 2012; 15(1-2):2-4. PubMed ID: 22465109
    [No Abstract]   [Full Text] [Related]  

  • 18. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.
    Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of acquired resistance to targeted cancer therapies.
    Lackner MR; Wilson TR; Settleman J
    Future Oncol; 2012 Aug; 8(8):999-1014. PubMed ID: 22894672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Trends in Cancer Drug Discovery-From Drugging the "Undruggable" to Overcoming Resistance.
    Rudolph J; Settleman J; Malek S
    Cancer Discov; 2021 Apr; 11(4):815-821. PubMed ID: 33811118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.